SEC warns pharma companies to be honest about FDA correspondence
March 03, 2015 at 17:16 PM EST
WASHINGTON, March 3 (Reuters) - The U.S. Securities and Exchange Commission's top enforcement chief warned on Tuesday that too many pharmaceutical companies are failing to accurately portray their dealings with federal drug regulators - a problem that could get them in trouble.
